Cochicine Treatment for Post- Operative Pericardial Effusion
Information source: French Cardiology Society
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pericardial Effusion
Intervention: Colchicines (Drug); Placebo (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: French Cardiology Society Official(s) and/or principal investigator(s): Philippe Meurin, MD, Principal Investigator, Affiliation: Clinique Les Grands Près - Villeneuve Saint Denis
Summary
Background: The incidence of asymptomatic pericardial effusion is high after cardiac
surgery.
Objective: To assess whether colchicine is effective in reducing post operative pericardial
effusion volume.
Design: Multicenter, randomized, double-blind, placebo-controlled study. Intervention :
colchicine 1mg vs placebo, once daily for 14 days Setting :10 post operative cardiac
rehabilitation centers. Patients: 200 patients at high risk of tamponade because of moderate
to large persistent pericardial effusion (grade 2, 3 or 4 on a scale of 0 to 4 measured by
echocardiography) more than 7 days after cardiac surgery.
Measurements: The main end point will be change in effusion grade after 14 days of
treatment. Secondary endpoints include frequency of late cardiac tamponade.
Clinical Details
Official title: Cochicine Treatment for Post- Operative Pericardial Effusion: The POPE 2 Study A Multicenter, Double-blind, Randomized Trial
Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: change in effusion grade
Secondary outcome: frequency of late cardiac tamponadenumber of patients with at least a one-grade decrease in the effusion mean change in the width of the effusion measured in millimeters evolution of prespecified subgroups
Detailed description:
Clinically insignificant pericardial effusion is common after heart surgery with an
incidence of 50 % to 85 % a few days after surgery Cardiac tamponade occurs in about 1-2 %
of patients who undergo cardiac surgery and may develop slowly without clear-cut clinical
signs. Most tamponade occurs more than 7 days after surgery which is a concern because, at
that time, patients often have already been discharged from the hospital.
No study has ever shown the efficacy any drug for this condition. In particular, we published
a study demonstrating the absence of efficacy of a non steroidal anti inflammatory drug
(Meurin P, Tabet JY, Thabut G, et al. French Society of Cardiology. Nonsteroidal
anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter
randomized, double-blind trial. Ann Intern Med. 2010 Feb2;152(3):137-43) Cochicine is widely
used to treat inflammatory pericarditis ; is it efficient to treat post operative
pericardial effusions ? this is the question we want to answer to.
Design: Multicenter, randomized, double-blind, placebo-controlled study. Intervention :
colchicine 1mg vs placebo, once daily for 14 days Setting :10 post operative cardiac
rehabilitation centers. Patients: 200 patients at high risk of tamponade because of moderate
to large persistent pericardial effusion (grade 2, 3 or 4 on a scale of 0 to 4 measured by
echocardiography) more than 7 days after cardiac surgery.
Measurements: The main end point will be change in effusion grade after 14 days of
treatment. Secondary endpoints include frequency of late cardiac tamponade.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- patients with recent cardiac surgery
- admitted for cardiac rehabilitation
- pericardial effusion > grade 2 (corresponds to a loculated effusion > 10
millimeters or a circumferential effusion of any size)on the first trans thoracic
echocardiography performed more than 7 days after surgery
Exclusion Criteria:
- patients who do not give written consent to participate
- pregnancy
- colchicine allergy;
- renal failure, which we define as a serum creatinine level > 250micromol/l or
clairance < 30 ml/mn
- heart transplantation,or correction of congenital heart anomalies cardiac surgery
more than 30 days before their first trans thoracic echocardiography pericardial
effusion that requires immediate drainage.
Locations and Contacts
Bois Gibert, Ballan Miré 37510, France
Centre Médical de Bligny, Briis sous Forges 91640, France
Clinique de Châtillon, Châtillon 92320, France
Centre Dieulefit Santé, Dieulefit 26220, France
Hopital Corentin Celton, Issy les moulineaux 92133, France
Clinique de la mitterie, Lomme 59160, France
Centre Hospitalier Loire Vendée Océan, Machecoul 44270, France
Clinique Iris, Marcy l'étoile 69280, France
Maison du mineur, Vence 06140, France
Clinique les Grands Près, Villeneuve Saint Denis 77174, France
Additional Information
Starting date: April 2011
Last updated: January 13, 2014
|